Archive - Venture Insider

The GLP-1 Second Wave — Weight Loss 2.0 Is Already Here, And It’s Oral

Three years ago, if you told a room full of Wall Street analysts that a diabetes drug would become the world’s best-selling pharmaceutical — bigger than…

4 hrs ago • Venture Insider

The Most Valuable Company in History Won’t Let You Buy a Single Share

I want to tell you about a company that just filed to go public at a valuation that would make it the largest IPO in the history of financial markets.

Mar 7 • Venture Insider

The hidden investment opportunity inside Europe's $800 billion rearmament

Six months ago, a fund manager based in Paris called me to talk about his defense exposure.

Mar 4 • Venture Insider

Why I’m Betting on Water — Not Chips — to Capitalize on the AI Bubble

Last week, I asked ChatGPT 47 questions to draft an investment memo.

Mar 3 • Venture Insider

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts